PHIA Koninklijke Philips N.V.

Philips introduces new cloud-enabled enterprise imaging informatics and analytics solutions at HIMSS22

Philips introduces new cloud-enabled enterprise imaging informatics and analytics solutions at HIMSS22

March 14, 2022

Philips advances precision care with new releases of HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge  

Amsterdam, the Netherlands and Orlando, Florida, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its latest introductions in analytics and interoperability solutions at the . Philips is a fully integrated cloud-enabled Health IT platform to meet diverse workflow needs across the imaging enterprise. – now provides operational insights and deep analytics beyond radiology to the cardiology department to enhance efficiencies and help improve effectiveness at the point of care. Both innovations are part of Philips’ Data Management and Interoperability Solutions portfolio [1], an integrated, scalable suite of innovative technology, analytics and professional services, designed to support healthcare providers to continuously improve performance.

“Building on our deep expertise in medical imaging and insights in enterprise informatics, this latest expansion of our Data Management and Interoperability Solutions portfolio will help drive sustainable change across imaging departments with enhanced efficiency and improved outcomes for patients and staff,” said , Chief Business Leader of Precision Diagnosis at Philips. “At HIMSS, we will showcase a highly-customizable set of data-driven solutions, delivering continuous improvement to meet clinical and business performance metrics with real-time insights.”

Advancing precision care with integrated data for meaningful insights

Every second, an exponential amount of healthcare data is generated and mined for valuable insights. Today, approximately 30% of the world’s data volume is being generated by the healthcare industry [2]. Successfully integrating healthcare data is complicated, with multiple user interfaces, complex systems and the slow retrieval of clinically relevant information, all of which hamper workflow efficiency and delay precision care. These challenges have been further exacerbated by COVID-19. At HIMSS, Philips will present how the company’s new Data Management and Interoperability Solutions portfolio is designed to enhance care planning and coordination with clinical and operational analytics to help improve workflow efficiency, patient and staff satisfaction and outcomes.  

Vendor-neutral solutions support data from imaging modalities on a common platform

The Data Management and Interoperability Solutions portfolio features two critical components. At HIMSS, Philips will spotlight , a fully integrated cloud-enabled health IT platform to meet diverse workflow needs across the imaging enterprise, connecting third-party systems and enabling seamless data workflows to streamline efficiency. This newest version of HealthSuite Interoperability will enable Philips to deliver integrated informatics solutions to help improve clinical workflow, enhance patient care and optimize enterprise management.





The platform will support all relevant data types and formats including DICOM (Digital Imaging and Communications in Medicine) images, genomics, pathology, laboratory data, HL7 (Health Level Seven International) standards, formats and definitions for exchanging and developing electronic health records messages, and FHIR (Fast Healthcare Interoperability Resources) standards. HealthSuite Interoperability will also support all major Electronic Medical Records (EMRs) vendors. Its clinical data repository also offers customers the ability to store and manage granular data, and can be used to create value driving solutions like health image exchanges.





Expanding beyond radiology to feature new cardiology analytics to enhance workflow

Philips’ Data Management and Interoperability Solutions also features the company’s newest enhancements in expanding operational insights and deep analytics beyond radiology to the cardiology department to enhance efficiencies and help improve effectiveness at the point of care. Philips Enterprise Performance Analytics – Performance Bridge – gives healthcare professionals access to near real-time data on departmental performance through an easy-to-use interactive dashboard. Its operational insights have driven performance improvements in multiple health systems including Miami Cardiac and Vascular Institute, where 100% of staff surveyed stated the Performance Bridge Patient Flow applications saves time in their workday and improves teamwork and communication [3]. Additionally, Kootenai Health in Idaho has leveraged the near real-time insights of Performance Bridge to improve their Cath Lab operations. Within 3 years, they have documented an increase in radial access rates associated with fewer complications, including major bleeding and mortality, from 9% to 42%, while improving patient comfort and shortening recovery times [4].

With these newest enhancements, cardiology departments now have access to critical metrics to support operational performance monitoring in an invasive procedural setting such as the interventional suite, providing data on procedure volumes, room utilization, procedure duration and lab turnaround time.  

Cardiology departments can also access key metrics designed to support operational performance monitoring in a non-invasive procedural setting such as cardiac imaging suites, most notably echocardiography, with access to data on procedure volumes, modality/machine utilization, study type counts and report turnaround time. This newest release further demonstrates Philips’ commitment to bring together the right combination of services and tools to measure and monitor key areas of improvement to help drive continuous improvement in radiology and cardiology departments to optimize operations, enhance workflow efficiencies and improve patient outcomes.

For more information on Philips’ full portfolio of connected informatics solutions being showcased in Booth #2501 at the HIMSS22 Global Health Conference & Exhibition, please visit and follow  for #HIMSS22 updates throughout the event.

[1] Pending 510(k) approval and not available for sale. For demonstration purposes only.

[2] .

[3] Patient Flow at MCVI: Interview Survey of Employees, Nov. 2021.

[4] Kootenai Health and Philips beta testing co-creation project, results tabulation from 2018-2021.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
14/03/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch